Fever, Respiratory Tract Infections
Conditions
Brief summary
To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement. Secondary objectives: * Qualitative evaluation of indication as well as adherence to the test result. * Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).
Interventions
DIAGNOSTIC_TESTBV
The use of the BV test, ordered at the discretion of the treating physician
Sponsors
Universität des Saarlandes
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
5 Months to No maximum
Healthy volunteers
No
Inclusion criteria
* Suspicion of acute bacterial or viral infection * Requirement of at least one BV test during medical presentation
Exclusion criteria
* lack of informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Antibiotics | up to 30 days | Number of participants treated with antibiotics |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Antibiotic duration | up to 30 days | Length of antibiotic treatment per participant |
| Hospitalization | up to 30 days | Number of participants admitted to the hospital |
| Complications | up to 30 days | Rate of complications per participant |
| Tests | up to 30 days | Rate of ancillary tests per participant |
Countries
Germany
Contacts
Primary ContactCihan Papan, MD
Backup ContactSoeren Becker, MD, PhD
Outcome results
None listed